STRN-ALK Fusion in a Case of Malignant Peritoneal Mesothelioma: Mixed Response to Crizotinib, Mode of Resistance, and Brigatinib Sequential Therapy

2021

Journal Article

Author(s)

Gerthofer, V.

Scheiter, A.

Lüke, F.

Keil, F.

Utpatel, K.

Pöhmerer, L.-M.-G.

Seitz, J.

Niessen, C.

Ignatov, A.

Dietmaier, W.

Calvisi, D.F.

Evert, M.

Ortmann, O.

Seitz, S.

Journal

JCO precision oncology